Xerox focuses on removing industry obstacles so you can focus on your core mission: improving lives through better, affordable, and accessible health care.

Vanda works to advance the science of developing new medicines through novel approaches to address unmet medical needs and improve the lives of patients.

Tobira is a clinical-stage biopharmaceutical company focused on developing innovative therapies to treat liver disease, inflammation, fibrosis and HIV.

Taiho strives to improve human health and contribute to a society enriched by smiles.

The State Institute for Drug Control (SUKL) regulates clinical trials in the Czech Republic. SUKL assesses some 350 clinical trial applications (CTAs) yearly.

Suanfarma Group specializes in the the pharmaceutical, biotechnological, veterinary, nutritional and cosmetic sectors.

Stratas Partners assists blue chip pharmaceutical companies and rises stars in strategic marketing, market access, health policy and medical affairs worldwide.

Smith & Nephew is a global medical technology business dedicated to helping improve people's lives with Orthopaedic Reconstruction, Trauma Extremities and Fixation.

Sigma-Tau Pharmaceuticals, Inc. is a rare corporation dedicated to creating novel medicines for the unmet needs of patients with rare diseases.

Shionogi Inc. is a pharmaceutical company with headquarters in Japan dedicated to developing medicines that protect the health and well-being of patients worldwide.

Sequentia Biotech is a young and dynamic company with expertise in the fields of bioinformatics, statistics, genetics and molecular biology.

Sanofi is a healthcare leader focused on patient's needs engaged in the research, development, manufacturing and marketing of therapeutic solutions.

Roche is committed to improving lives since the company was founded, creating innovative medicines and diagnostic tests to help millions of patients globally.

Rempex, acquired by The Medicines Company on December 4, 2013 engages in the discovery and development of antibacterial drugs for antibiotic resistance.

Regeneron focuses on bringing innovative thinking to the challenge of discovering and developing new medicines to improve therapeutic outcomes for patients.

PTC Therapeutics is a specializes in RNA biology, focusing on developing novel oral treatments for patients with serious and life-limiting disorders.

Novimmune focuses on the development of antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders, and cancer.

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

NephroGenex is an innovator in the development of drugs to treat kidney disease, with a first indication in diabetic nephropathy.

Healthcare advertising Agency specialized in life sciences.

Mesoblast is a world leader in developing innovative cellular medicines.

Merck is one of the world's leading pharmaceutical, chemical and life science companies, leader in science, technology, healthcare, life science and performance materials.

Medpace is a global leader CRO, building strong strategic partnerships with Sponsors to advance the most efficient and cost-effective path to approval.

Loxo Oncology is innovating the development of highly selective medicines for patients with genetically defined cancers.

Kyowa Hakko Kirin is a research-based life sciences company with special strengths in biotechnology.

Ionis Pharmaceuticals is the leading company in RNA-targeted drug discovery and development, exploiting a proven novel drug discovery platform.

IRB Barcelona is a world-class research centre devoted to understanding fundamental questions about human health and disease.

Innate Pharma is a biopharma company discovering and developing first-in-class therapeutic antibodies for the treatment of cancer and inflammatory diseases.

Incyte is a leading biopharma company building a pipeline of novel small molecule drugs for serious unmet medical needs primarily in the area of oncology.

Immunomedics is a leading biopharmaceutical company, dedicated to improving patient's health and quality of life with novel antibody–based therapeutics.

Helsinn is a world leading cancer care company aiming to improve the health and quality of life for every person with cancer - today, now, when it counts.

GCP-Service is a 100% privately owned full-service CRO with the scope to conduct a wide variety of clinical studies, meeting individual and specific needs of clients.

Glycotope is a global leader in Glycobiology developing new and proprietary biopharmaceuticals with optimized and fully human glycosylation structures.

Gilead is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in unmet medical need.

Epizyme® is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers.

Emminens, company of the Roche Group, is a leader in the design of technological solutions for the personalized management of chronic diseases.

DePuy Synthes, part of the Johnson & Johnson Family offers the world’s most comprehensive portfolio of orthopaedic and neuro products and services.

Coherus is a leading developer of high-quality biosimilar therapeutics driven by a common mission: improving patient benefit by expanding access to biologic drugs.

Digital CRO with global full-service digital contract research organization (dCRO), pioneering an innovative service model to serve the needs of biomedical firms.

Clementia is a biopharmaceutical company focused on developing a treatment for Fibrodysplasia Ossificans Progressiva (FOP).

ChemoCentryx is a biopharma company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases.

Braeburn is a phase III pharma company, focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders.

Auris Medical is a Swiss biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in otology.

AstraZeneca is a global, science-led biopharmaceutical business and its innovative medicines are used by millions of patients worldwide.

Astex is a leader in innovative drug discovery and development, committed to the fight against cancer and diseases of the central nervous system.

Astellas is a global pharmaceutical company with a simple vision – to produce exceptional medicines that change tomorrow for patients in need.

Argos is a biopharma company focused on the development of fully personalized immunotherapies for the treatment of cancer and infectious diseases.

ANSM is the French regulatory agency responsible for assessing the benefits and risks associated with the use of health products throughout their life-cycle.

Ambit focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases.

Alnylam leads the translation of RNAi as a new class of innovative medicines, with a core focus on RNAi therapeutics for the treatment of serious, life-threatening diseases.

Alder is a clinical-stage biopharma company that discovers and develops therapeutic antibodies with the potential to transform current treatment paradigms.

The Italian Medicines Agency (AIFA) is the national authority responsible for drugs regulation in Italy, under the direction of the Ministry of Health.

The AEMPS is the regulatory agency that oversees the quality, safety and efficacy of pharmaceuticals and medical devices in Spain.